載入...
Successful treatment of secondary poor graft function post allogeneic hematopoietic stem cell transplantation with eltrombopag
Poor graft function (PGF) is a life-threatening complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Current treatment strategies include the use of growth factors, CD34(+)-selected stem cell boost, mesenchymal stem cell transfusion, and second allo-HSCT, but these trea...
Na minha lista:
| 發表在: | J Hematol Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6097332/ https://ncbi.nlm.nih.gov/pubmed/30115080 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-018-0649-6 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|